Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -11.6% | -33.5% | 0 / 3 | +40.0% | -4.18 pp | -1.09 pp | +8.1% | 0.31 | 19.81 | 353 | +40,0% | 6,6 | −11,6% | 19.81 | 10.04 | +97,4% |
| Pts | 0 | 0 | 0 | 12 | 0 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 29.500 (close price on 2026-10-19)EPS (TTM): 1.489
Financial charts
1.Revenue & growth
VND bn353Q2/26
1.Revenue & growth
VND bn353Q2/26
2.Profit & growth
VND bn6,56Q2/26
3.Profit mix (Penman)
VND bn30,5Q2/26
4.Margins & cost structure
%12.2%Q2/26
5.Returns & cash cycle
% · days9.2%Q2/26
6.Earnings quality & cash
VND bn6,50Q2/26
7.Asset structure
VND bn623Q2/26
8.Funding & debt health
VND bn · times623Q2/26
9.Revenue backlog
VND bn173Q2/26
10.Valuation
times · %19,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %398Q2/26
Adjusted EPS growth, latest quarter
-11.6%
Average adjusted EPS growth, 3 quarters
-33.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26